News

Published on 27 Mar 2024 on Insider Monkey via Yahoo Finance

Analysts on Wall Street Lower Ratings for These 10 Stocks


Article preview image

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts on Wall Street Lower Ratings for These 5 Stocks.

In the realm of cautious trading before the quarter concludes, global stocks in Asia witnessed a mixed performance. As investors brace for the Federal Reserve's upcoming release of crucial inflation data later this week, a sense of prudence prevails. Japan's Finance Minister issued a cautionary note against excessive fluctuations in the yen, underscoring the sensitivity of currency markets amid uncertain economic conditions. In this landscape, Julius Baer discerns a trend of capital flowing into Japanese equities, marking a potential shift in investment patterns. This observation hints at evolving investor sentiments and strategic reallocations within the financial markets.

Looking ahead, all eyes are on the Federal Reserve's forthcoming release of its key inflation gauge data, slated for Friday. This data release is expected to provide crucial insights into the trajectory of inflation, influencing market sentiment and potentially steering investor strategies in the days to come. As traders navigate through these uncertain waters, the cautious stance underscores the importance of strategic positioning and prudent risk management in the ever-fluctuating landscape of global financial markets.

NASDAQ.PZZA price evolution
NYSE.VLO price evolution
NYSE.PFE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
13 Best Ethical Companies to Invest in 2024

In this piece, we will take a look at the 13 best ethical companies to invest in 2024. If you wan...

Insider Monkey via Yahoo Finance 24 Apr 2024

Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...

Moderna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London p...

Benzinga 23 Apr 2024

10 Best Performing Biotech ETFs in 2024

In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our ...

Insider Monkey via Yahoo Finance 22 Apr 2024

EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)

EU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...

Seeking Alpha 22 Apr 2024

11 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you wa...

Insider Monkey via Yahoo Finance 21 Apr 2024

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a go...

Zacks via Yahoo Finance 19 Apr 2024

Big pharma: cautious optimism ahead of earnings season - analysts

Looking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking...

Proactive Investors 18 Apr 2024

Pfizer-Connect Biopharma deal for inflammatory drug ends

Connect Biopharma (CNTB) terminates licensing deal with Pfizer (PFE) for CBP-174, an oral...

Seeking Alpha 17 Apr 2024

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff...

Benzinga via Yahoo Finance 16 Apr 2024

A Win for the SEC on Shadow Trading. Now What?

The lawsuit, which survived both a motion to dismiss (read here) and motion for summary judgment ...

The National Law Review 15 Apr 2024